ASAH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.91102689228728E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.0300000014295E-08 |
Normal-vs-Stage2 |
4.35739999999907E-05 |
Normal-vs-Stage3 |
1.62458935193399E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
7.476000E-01 |
Stage1-vs-Stage3 |
8.23690000000266E-05 |
Stage1-vs-Stage4 |
1.17779999997403E-06 |
Stage2-vs-Stage3 |
4.986100E-02 |
Stage2-vs-Stage4 |
9.999500E-03 |
Stage3-vs-Stage4 |
2.078800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
1.570620E-01 |
Normal-vs-Asian |
8.194400E-01 |
Caucasian-vs-AfricanAmerican |
1.275600E-01 |
Caucasian-vs-Asian |
3.910600E-01 |
AfricanAmerican-vs-Asian |
7.600200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.54337999999088E-05 |
Male-vs-Female |
1.418370E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.014800E-01 |
Normal-vs-Age(41-60Yrs) |
1.96029859012015E-11 |
Normal-vs-Age(61-80Yrs) |
1.62536650805123E-12 |
Normal-vs-Age(81-100Yrs) |
3.18060000004117E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.075200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.318200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.941800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.502000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.089800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.945000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.342200E-01 |
Normal-vs-Grade 2 |
1.29280000038534E-08 |
Normal-vs-Grade 3 |
1.63091762317435E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.000170E-01 |
Grade 1-vs-Grade 3 |
1.124410E-01 |
Grade 1-vs-Grade 4 |
3.641600E-02 |
Grade 2-vs-Grade 3 |
4.584200E-02 |
Grade 2-vs-Grade 4 |
2.42059999999711E-06 |
Grade 3-vs-Grade 4 |
1.280390E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.01179953304609E-10 |
Normal-vs-ccB subtype |
4.25489976585425E-10 |
ccA subtype-vs-ccB subtype |
4.643900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.24589960149547E-10 |
Normal-vs-N1 |
8.24618151540335E-12 |
N0-vs-N1 |
1.078270E-03 |
|
|